Literature DB >> 10639472

Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

J M Vuola1, V Puurula, M Anttila, P H Mäkelä, N Rautonen.   

Abstract

The role of gamma interferon (IFN-gamma) in a Chlamydia pneumoniae mouse model was studied by in vivo neutralization in two inbred mouse strains. During primary C. pneumoniae infection, neutralization of IFN-gamma increased both the numbers of bacteria and the pneumonia score in the lungs of C57BL/6 mice but not BALB/c mice. During reinfection, the bacterial counts in the lungs were increased by IFN-gamma neutralization in both mouse strains. Thus, the effect of IFN-gamma neutralization was dependent on the genetic background in primary infection. However, IFN-gamma appeared to be equally important in both mouse strains during reinfection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639472      PMCID: PMC97231          DOI: 10.1128/IAI.68.2.960-964.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 2.  The biological relevance of polykaryons in the immune response.

Authors:  S Fais; V L Burgio; M R Capobianchi; S Gessani; F Pallone; F Belardelli
Journal:  Immunol Today       Date:  1997-11

3.  Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Authors:  T Darville; C W Andrews; K K Laffoon; W Shymasani; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice.

Authors:  J M Penttilä; M Anttila; K Varkila; M Puolakkainen; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

5.  Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.

Authors:  M E Rottenberg; A C Gigliotti Rothfuchs; D Gigliotti; C Svanholm; L Bandholtz; H Wigzell
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

6.  CD8+ T cells are activated during the early Th1 and Th2 immune responses in a murine Lyme disease model.

Authors:  Z Dong; M D Edelstein; L J Glickstein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?

Authors:  M Johansson; K Schön; M Ward; N Lycke
Journal:  Scand J Immunol       Date:  1997-12       Impact factor: 3.487

8.  Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Authors:  J M Penttilä; M Anttila; M Puolakkainen; A Laurila; K Varkila; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection.

Authors:  M F Lampe; C B Wilson; M J Bevan; M N Starnbach
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

Authors:  D M Williams; J Schachter; D J Drutz; C V Sumaya
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

View more
  7 in total

1.  Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

Authors:  C Scott Little; Andrew Bowe; Richard Lin; Jason Litsky; Robert M Fogel; Brian J Balin; Kerin L Fresa-Dillon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism.

Authors:  Meike Eickhoff; Jessica Thalmann; Simone Hess; Myriam Martin; Thomas Laue; Joachim Kruppa; Gudrun Brandes; Andreas Klos
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

3.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Authors:  Chengming Wang; Frederik W van Ginkel; Teayoun Kim; Dan Li; Yihang Li; John C Dennis; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

5.  Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.

Authors:  Anne Sarén; Steve Pascolo; Stefan Stevanovic; Tilman Dumrese; Mirja Puolakkainen; Matti Sarvas; Hans-Georg Rammensee; Jenni M Vuola
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

6.  Effect of age and vaccination on extent and spread of Chlamydia pneumoniae infection in C57BL/6 mice.

Authors:  Taylor Eddens; Sarah Beaudoin; Amanda Steinberger; C Scott Little; Dawn Shell; Benjamin Wizel; Brian Balin; Kerin L Fresa-Dillon
Journal:  Immun Ageing       Date:  2012-05-17       Impact factor: 6.400

Review 7.  Biomarkers in the Management of Difficult Asthma.

Authors:  Florence Schleich; Sophie Demarche; Renaud Louis
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.